s2wR != mse, FDA != EMA [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2017-03-04 20:13 (2581 d 18:35 ago) – Posting: # 17133
Views: 17,964

I like that post, d_labes :-),


❝ But s2wR = MSE is not necessarily true in all cases, although it is in many cases a reasonable assumption.


...and accordingly when the optimizer fails, plugging in the GLM residual (expressed as MSE) as a new starter value for s2wR (and even S2wT where applicable) may be a very decent last-ditch attempt.

❝ Moreover the FDA evaluation uses intra-subject constrasts to evaluate s2wR


What does this mean? Don't you usually get it from the REML covarance matrix?

I think EMA's approach can be condensed into intra-Subject contrasts to derive S2wR from completers.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
106 visitors (0 registered, 106 guests [including 12 identified bots]).
Forum time: 14:49 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5